Phreesia Q2 FY2023 revenue $67.9M (+33% YoY); raises FY revenue and EBITDA guidance

Phreesia, Inc.

2023-Q2 EPS reported -$1.88 revenue$131,221,000

Revenue $67.9M, up 33% YoY; average healthcare clients 2,776 (+40% YoY).
Adjusted EBITDA loss widened to $26.0M from $11.0M in prior year.
FY2023 revenue guidance raised to $273M-$275M; Adj. EBITDA guidance improved to negative $106M-$109M.
Cash $240.7M, down $73.1M from Jan; expects $165M-$170M by Jan 31, 2023.
Average revenue per healthcare client $18,248, down 7% YoY as client growth outpaced payment volume.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.